3326 - 3350 of 9034 Results
Title
Year
- A single-cell atlas to map sex-specific gene-expression changes in blood upon neurodegeneration2025OPENTitle: A single-cell atlas to map sex-specific gene-expression changes in blood upon neurodegenerationJournal Name: Nature CommunicationsPublisher: Springer Science and Business Media LLCVol: 16Issue #: 1Start Page: 1965End Page: 1965Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41467-025-56833-7Best OA location URL: https://www.nature.com/articles/s41467-025-56833-7.pdfCitation Count: 11
-
OPENTitle: Forecasts for the Attainment of Major Research Milestones in Parkinson’s DiseaseJournal Name: Journal of Parkinson's DiseasePublisher: SAGE PublicationsVol: 10Issue #: 3Start Page: 1047End Page: 1055Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.3233/jpd-201933Best OA location URL: https://doi.org/10.17863/cam.52302Citation Count: 4
-
OPENTitle: Increased expression of the dopamine transporter leads to loss of dopamine neurons, oxidative stress and l-DOPA reversible motor deficitsJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 74Issue #:Start Page: 66End Page: 75Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.nbd.2014.10.016Best OA location URL: http://doi.org/10.1016/j.nbd.2014.10.016Citation Count: 158
- Selective Fluorogenic β-Glucocerebrosidase Substrates for Convenient Analysis of Enzyme Activity in Cell and Tissue Homogenates2020OPENTitle: Selective Fluorogenic β-Glucocerebrosidase Substrates for Convenient Analysis of Enzyme Activity in Cell and Tissue HomogenatesJournal Name: ACS Chemical BiologyPublisher: American Chemical Society (ACS)Vol: 15Issue #: 4Start Page: 824End Page: 829Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1021/acschembio.9b01044Citation Count: 12
-
OPENTitle: Discovery and characterization of N-(1,3-dialkyl-1H-indazol-6-yl)-1H-pyrazolo[4,3-b]pyridin-3-amine scaffold as mGlu4 positive allosteric modulators that mitigate CYP1A2 induction liabilityJournal Name: Bioorganic & Medicinal Chemistry LettersPublisher: Elsevier BVVol: 28Issue #: 15Start Page: 2641End Page: 2646Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.bmcl.2018.06.034Best OA location URL: https://doi.org/10.7270/q2dr2z5hCitation Count: 14
-
OPENTitle: The GBA1 D409V mutation exacerbates synuclein pathology to differing extents in two alpha-synuclein modelsJournal Name: Disease Models & MechanismsPublisher: The Company of BiologistsVol: 15Issue #: 6Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1242/dmm.049192Best OA location URL: https://journals.biologists.com/dmm/article-pdf/15/6/dmm049192/2145803/dmm049192.pdfCitation Count: 18
-
RESTRICTEDTitle: A Multi-network Approach Identifies Protein-Specific Co-expression in Asymptomatic and Symptomatic Alzheimer’s DiseaseJournal Name: Cell SystemsPublisher: Elsevier BVVol: 4Issue #: 1Start Page: 60End Page: 72.e4Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.cels.2016.11.006Best OA location URL: http://doi.org/10.1016/j.cels.2016.11.006Citation Count: 532
-
OPENTitle: Bimolecular Fluorescence Complementation of Alpha-synuclein Demonstrates its Oligomerization with Dopaminergic Phenotype in MiceJournal Name: EBioMedicinePublisher: Elsevier BVVol: 29Issue #:Start Page: 13End Page: 22Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.ebiom.2018.01.035Best OA location URL: http://www.thelancet.com/article/S2352396418300392/pdfCitation Count: 31
-
OPENTitle: Identification of small molecules that bind to the mitochondrial protein mitoNEETJournal Name: Bioorganic & Medicinal Chemistry LettersPublisher: Elsevier BVVol: 26Issue #: 21Start Page: 5350End Page: 5353Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.bmcl.2016.09.009Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/5482219Citation Count: 40
-
OPENTitle: Safety and tolerability of putaminal AADC gene therapy for Parkinson diseaseJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 73Issue #: 20Start Page: 1662End Page: 1669Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1212/wnl.0b013e3181c29356Best OA location URL: https://n.neurology.org/content/neurology/73/20/1662.full.pdfCitation Count: 429
-
OPENTitle: Fyn Knock-Down Prevents Levodopa-Induced Dyskinesia in a Mouse Model of Parkinson’s DiseaseJournal Name: eneuroPublisher: Society for NeuroscienceVol: 8Issue #: 4Start Page: ENEURO.0559End Page: 20.2021Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1523/eneuro.0559-20.2021Best OA location URL: https://www.eneuro.org/content/eneuro/8/4/ENEURO.0559-20.2021.full.pdfCitation Count: 14
- Retigabine, a KV7 (KCNQ) potassium channel opener, attenuates l-DOPA-induced dyskinesias in 6-OHDA-lesioned rats2011RESTRICTEDTitle: Retigabine, a KV7 (KCNQ) potassium channel opener, attenuates l-DOPA-induced dyskinesias in 6-OHDA-lesioned ratsJournal Name: NeuropharmacologyPublisher: Elsevier BVVol: 62Issue #: 2Start Page: 1052End Page: 1061Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.neuropharm.2011.10.016Citation Count: 24
-
OPENTitle: Putting participants and study partners FIRST when clinical trials end earlyJournal Name: Alzheimer's & DementiaPublisher: WileyVol: 18Issue #: 12Start Page: 2736End Page: 2746Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/alz.12732Best OA location URL: https://doi.org/10.1002/alz.12732Citation Count: 10
- Neuropathic Gaucher’s Mutations: Shifting Parkinson’s Into High Gear (S1.002)2017RESTRICTEDTitle: Neuropathic Gaucher’s Mutations: Shifting Parkinson’s Into High Gear (S1.002)Journal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 88Issue #: 16_supplementStart Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1212/wnl.88.16_supplement.s1.002Citation Count: 0
- Video research visits for atypical parkinsonian syndromes among Fox Trial Finder participants (P3.8-006)2019RESTRICTEDTitle: Video research visits for atypical parkinsonian syndromes among Fox Trial Finder participants (P3.8-006)Journal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 92Issue #: 15_supplementStart Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1212/wnl.92.15_supplement.p3.8-006Citation Count: 0
- Modeling PD Progression in the PPMI Cohort: Implications for Clinical Trial Design (4402)2020RESTRICTEDTitle: Modeling PD Progression in the PPMI Cohort: Implications for Clinical Trial Design (4402)Journal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 94Issue #: 15_supplementStart Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1212/wnl.94.15_supplement.4402Citation Count: 0
-
OPENTitle: Characterizing molecular and synaptic signatures in mouse models of late‐onset Alzheimer's disease independent of amyloid and tau pathologyJournal Name: Alzheimer's & DementiaPublisher: WileyVol: 20Issue #: 6Start Page: 4126End Page: 4146Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/alz.13828Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/alz.13828Citation Count: 31
-
OPENTitle: Brain Serotonin Release Is Reduced in Patients With Depression: A [11C]Cimbi-36 Positron Emission Tomography Study With a d-Amphetamine ChallengeJournal Name: Biological PsychiatryPublisher: Elsevier BVVol: 93Issue #: 12Start Page: 1089End Page: 1098Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.biopsych.2022.10.012Citation Count: 83
- The Coalition Against Major Diseases: Dopamine Transporter Neuroimaging as an Enrichment Biomarker To Enable Parkinson's Disease Clinical Trials (P06.049)2013RESTRICTEDTitle: The Coalition Against Major Diseases: Dopamine Transporter Neuroimaging as an Enrichment Biomarker To Enable Parkinson's Disease Clinical Trials (P06.049)Journal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 80Issue #: 7_supplementStart Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1212/wnl.80.7_supplement.p06.049Citation Count: 2
- Reaction-Based “Off–On” Fluorescent Probe Enabling Detection of Endogenous Labile Fe2+ and Imaging of Zn2+-induced Fe2+ Flux in Living Cells and Elevated Fe2+ in Ischemic Stroke2015RESTRICTEDTitle: Reaction-Based “Off–On” Fluorescent Probe Enabling Detection of Endogenous Labile Fe2+ and Imaging of Zn2+-induced Fe2+ Flux in Living Cells and Elevated Fe2+ in Ischemic StrokeJournal Name: Bioconjugate ChemistryPublisher: American Chemical Society (ACS)Vol: 27Issue #: 2Start Page: 302End Page: 308Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1021/acs.bioconjchem.5b00259Citation Count: 72
-
OPENTitle: Sex differences in the diagnosis latency of Parkinson's disease in Latin AmericaJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 134Issue #:Start Page: 107344End Page: 107344Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.parkreldis.2025.107344Best OA location URL: https://doi.org/10.1016/j.parkreldis.2025.107344Citation Count: 1
- Changing the research criteria for the diagnosis of Parkinson's disease: obstacles and opportunities2013RESTRICTEDTitle: Changing the research criteria for the diagnosis of Parkinson's disease: obstacles and opportunitiesJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 12Issue #: 5Start Page: 514End Page: 524Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(13)70047-4Citation Count: 154
-
OPENTitle: Novel oligodendroglial alpha synuclein viral vector models of multiple system atrophy: studies in rodents and nonhuman primatesJournal Name: Acta Neuropathologica CommunicationsPublisher: Springer Science and Business Media LLCVol: 5Issue #: 1Start Page: 47End Page: 47Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1186/s40478-017-0451-7Best OA location URL: https://actaneurocomms.biomedcentral.com/track/pdf/10.1186/s40478-017-0451-7Citation Count: 57
-
OPENTitle: Review of the Effects of Lifestyle Modification on Parkinson’s DiseaseJournal Name: American Journal of Lifestyle MedicinePublisher: SAGE PublicationsVol:Issue #:Start Page: 15598276251384591End Page: 15598276251384591Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1177/15598276251384591Best OA location URL: https://pmc.ncbi.nlm.nih.gov/articles/PMC12494586/Citation Count: 0
- Stress and Mindfulness in Parkinson's Disease: Clinical Effects and Potential Underlying Mechanisms2020OPENTitle: Stress and Mindfulness in Parkinson's Disease: Clinical Effects and Potential Underlying MechanismsJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 1Start Page: 64End Page: 70Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mds.28345Best OA location URL: https://movementdisorders.onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.28345Citation Count: 74